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INTRODUCTION
Several studies have recently focused on the rapid
vasodilation elicited by external muscle compression (1-3)
suggesting that, like the classical myogenic response, it is at least
partly mediated by mechanosensitive mechanisms responding to
a reduction in transmural pressure (2, 4, 5).
Understanding the mechanisms of vascular mechano-
sensitivity is of primary importance for its potential contribution
to the regulation of vascular tone and, consequently, of vascular
resistance and arterial blood pressure (6-8).
Mechano-sensitivity of blood vessels is considered to rely
mostly on mechano-sensitive channels (MSC), largely expressed
by both endothelium and vascular smooth muscle (2, 9).
Selective blockade of these channels has been attempted in in
vitro studies (10, 11) by means of different substances such as
4,4'-diisothiocyano-2,2'-stilbenedisulfonic acid (DIDS),
tarantula protein (GsMtx2), gadolinium (Gd3+) (10). Although
being characterized by low specificity (12), gadolinium (Gd3+, a
trivalent lanthanide), has been widely used as MSC blocker, to
test mechano-sensitivity of single cells (11) and isolated vessel
preparations (13). In particular Gd3+ was shown to provoke
marked attenuation of the classical myogenic response (13), i.e.
the slow (lasting about 1 min) vascular constriction/dilatation
occurring in response to step increase/decrease in the vessel's
transmural pressure. However, to our knowledge the effect of
MSC blockade has never been tested on the rapid dilatory
response induced by a short lasting muscle compression.
Aim of the present work is to test the role of mechano-
sensitive ion channels on the rapid hyperaemic response induced
by external compression of the masseter muscle in anesthetized
rabbits, by assessing the effect of Gd3+ administration. A recently
developed model has been employed, which allows for accurate
monitoring of blood flow from the purely muscular masseteric
artery (14). This vascular bed appears to be very reactive to
mechanical stimuli and the ensuing hyperaemic events can be
produced with high repeatability by muscle compression (5, 15).
One of the reason why Gd3+ has been little investigated in
vivo is related to its toxic effect, possibly resulting in
hypotension, cardiac arrhythmias, A-V bundle block, ventricular
fibrillation when administered systemically (16). In order to
overcome acute collateral effects and prevent disturbing
cardiovascular changes at systemic level, Gd3+ was here locally
administered in small doses through close arterial injection.
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Aim of the present study is to investigate the role of mechano-sensitive channels on basal muscle blood flow and
on the compression-induced rapid hyperaemia. To this aim, the mechano-sensitive channel blocker Gadolinium
(Gd3+) is employed, which already proved to reduce the myogenic response in isolated vessels. Muscle blood flow
(MaBF) was recorded from the masseteric artery in 8 urethane-anesthetized rabbits. Rapid hyperemic responses
were evoked by 1-s lasting compressions of the masseter muscle (MC) delivered before and after close arterial
infusion of Gd3+ in the masseteric artery. Three infusions were performed at 1-h interval, producing estimated
plasma concentration (EPC) of 0.045, 0.45 and 4.5 mM, in the masseteric artery. The amplitude of the hyperaemic
response to MC, equal to 195±77% of basal flow in control condition, was reduced by 9.5±19.4% (p=0.18) and
45±28% (p<0.01) while basal MaBf increased by 10±3% (p=0.90) and by 68±30% (p<0.01) at EPC of 0.045 and
0.45 mM, respectively. At EPC of 4.5 mM a strong reduction in both MaBF (by 54±13%, p<0.01) and MC response
(75±12%, p<0.01) was instead observed. These effects did not depend on time from infusion. At all doses employed
Gd3+ never affected arterial blood pressure, heart rate and contralateral MaBF. While the effects observed at the
highest EPC likely result from blood vessel occlusion due to Gd3+ precipitation, the effects observed at lower
concentrations demonstrate that Gd3+ affects musculo-vascular function by decreasing both resting vascular tone and
responsiveness to mechanical stimuli. The results are compatible with a Gd3+-induced blockade of vascular
mechano-sensitive channels.
K e y  w o r d s : gadolinium, muscle blood flow, mechano-transduction, rapid dilatation, mechano-sensitive channel, myogenic
effect, masseter muscle
MATERIAL AND METHODS
The study was performed in accordance with the principles
of laboratory animal care. Purposes and protocols were approved
by the Ethical Committee for Animal Experiments at the
University of Turin.
Surgical procedure
Experiments were carried out on 8 male European rabbits
(Oryctolagus cuniculus) weighing between 3.1 and 3.9 kg,
anesthetized with urethane (Urethane, Sigma Aldrich, 1.2 g/kg
i.v.). Full surgical anaesthesia was maintained by injecting
additional doses of the drug (0.4 g/kg i.v,) through a catheter
inserted in the cannulated left femoral vein. In all animals
trachea was intubated and the head was fixed in a stereotaxic
frame by screws implanted in the nasal and frontal bones.
A telemetric pressure transducer (TA11PA-D70, DSI - St. Paul,
MN, USA) was implanted, the catheter being inserted into the right
femoral artery for monitoring arterial blood pressure (ABP).
A perivascular flow probe (model 0.7 PSB, Transonic
Systems Inc, Itaha, NY, USA) was implanted on the masseteric
branch of the facial artery (Ma). The Ma, which exclusively
supplies the rostral portion of the masseter muscle, was isolated
medially to the mandibular margin, immediately after its
branching from the facial artery, for placement of the probe (14).
In 5 of 8 animals a bilateral implant was performed so that blood
flow could be recorded simultaneously from the left and right
masseteric artery.
A silicone cannula (diameter 0.5 mm, CNC-3IS-LSA/LSP
Access Technologies, USA) was inserted at the distal
mandibular end of the facial artery and advanced proximally, up
to the origin of the Ma, for close arterial injection of Gd3+ in the
masseter muscle. The cannula was continuously perfused with
saline solution at 2–3 ml/h (infusion pump Terumo Europe STC-
521, Leuven, Belgium) to prevent clotting.
The experimental procedures started after stabilization of the
hemodynamic variables, about 1 hour after the surgical
preparation was completed. At the end of the experiments animals
were killed with an i.v. injection of a lethal dose of urethane.
Drugs
Gadolinium chloride (Gd3+, Sigma, Steinhein, Germany), an
antagonist of stretch-activated cation channels, was dissolved in
HEPES buffer (pH 7.3–7.4) (17-19) and infused at increasing
concentrations of 0.1 mM, 1.0 mM and 10 mM into the
cannulated facial artery, through an infusion pump (Terumo
STC-521, Terumo Co., Tokyo). The rate of injection was set to
50% of basal blood flow in the masseteric artery, ranging
between 6 and 24 ml/h, for a duration of 2 minutes. This
approach was aimed to obtain the same Gd3+ plasma
concentration in all masseteric arteries. Given that rabbit
haematocrit is about 40% (20), the estimated plasma
concentration (EPC) of Gd3+ in masseteric artery during drug
infusion approximately corresponds to 0.045–0.45–4.5 mM for
the three dosages employed. The three administrations were
separated by 1-h lasting intervals, during which changes in basal
blood flow and vascular reactivity were assessed.
Mechanical stimulation
Mechanical compression of the masseter muscle was
performed unilaterally by means of a shaker (model V2, Data
Physics Corporation, San Jose, CA USA), driven by a computer-
generated trapezoidal signal (rise time: 0.1 s; plateau: 1 s; return:
0.1 s), delivered through a 1401 micro I/O board (CED,
Cambridge, UK). The shaker was armed with a cylindrical head
(diameter of about 1.3 cm, amplitude of movement up to 5 mm)
positioned so that it exerted appropriate and repeatable
compressions of the cheek at the level of the anterior portion of
the masseter muscle (5). Mechanical stimuli were delivered in
series of 10 MCs separated by 30-s intervals. This inter-stimulus
interval was maintained precisely constant (PC-controlled) since
it was observed to affect the amplitude of the hyperemic
response to MC (15).
One series was delivered before the first Gd3+ administration
(control), then other series were periodically delivered at 3.5, 15,
30 and 45 min after the end of each Gd3+ infusion, as illustrated
in Fig. 1.
Data acquisition and processing
Acquisition of all signals and off-line processing were
performed with Spike2 (CED, Cambridge, UK). Simple
algorithms were implemented in the Spike2 script language
aimed at identifying single cardiac cycles (based on systolic
peak detection on the ABP signal), from which time averages of
the different signals (one value per cardiac cycle) were
computed. Measurement of ABP, heart rate (HR) and masseteric
410
3.5 15 min30 45
Gd3+
Gd3+ 0.045 0.45 4.5 mM
1 h 1 h
Stim.
Stim.
Fig. 1. Scheme describing the
experimental protocol mechanical
stimulation. It was composed by 5
series of 10 MC (30 second between
each one). The series was started before
Gd3+ administration (control), after 3.5
minutes (t3.5), after 15 minutes (t15),
after 30 minutes (t30) and after 45
minutes (t45). This sequence was
repeated (0.045 mM–0.45 mM–4.5
mM).
artery blood flow ipsilateral (iMaBF) and contralateral (cMaBf)
to the side of mechanical stimulation and of Gd3+ injection were
continuously performed. The blood flow response to MC was
characterized in terms of peak flow response and peak amplitude
(=peak flow-basal low). These measurements were taken before
and 4 times after each Gd3+ injection (at. 3.5, 15, 30, 45 min,
after injection). Basal flow and peak flow of hyperaemic
responses were normalized to the basal flow of the control
condition (i.e., before the first Gd3+ injection). In addition, the
peak amplitude of the hyperaemic response was normalized to
the pre-stimulus level. For all variables the average effects were
computed across all animals (n=8) and reported as mean ±
standard deviations (S.D.).
Statistical significance of the effect of Gd3+ on the measured
variables was assessed with a two-ways ANOVA and Duncan
Post hoc test, with time from injection (time: 3.5, 15, 30, 45 min)
and Gd3+ concentration (EPC: 0.045, 0.45, 4.5 mM) as factors.
RESULTS
In control conditions MaBF ranged between 0.2 and 1 ml/min,
on average 0.44±0.08 ml/min. Compression of the masseter
muscle produced a transient reduction in iMaBF, followed by a
rapid hyperaemic response, developing immediately after release
of the stimulus (peak amplitude: 0.85±0.33 ml/min, time to peak:
2.2±0.8 s) and returning to control within 10–15 sec. A
representative example of the hyperaemic response to subsequent
stimuli is shown in Fig. 2A.
Neither ABP nor HR nor cMaBF were statistically
dependent on the time from Gd3+ injection (p=0.74) or on the
concentration of the drug (p=0.95), indicating that Gd3+ did not
reach the general circulation at a concentration sufficient to be
effective. On average, ABP, HR and cMaBF were 96.1±5.8
mmHg, 308±10 bmp and 0.36±0.13 ml/min, respectively.
Administration of Gd3+ at increasing concentration
progressively decreased the amplitude of the hyperaemic
response to MC, while also affecting basal blood flow. A
representative example is shown in Fig. 2B in which the average
responses to MC collected 45 min after Gd3+ administration at
different concentrations (progressively lighter grey traces
corresponding to increasing concentrations) are superimposed to
the MC response in control condition (black trace). It can be
observed that the decrease in the amplitude of response occurs
independently of an effect on basal blood flow.
The time course of peak amplitude (light grey) and basal
flow (dark grey) is reported in Fig. 3A, the full height of each bar
thus representing peak flow. None of the variables exhibited a
dependence on time from Gd3+ administration (peak flow:
p=0.51; basal flow: p=0.20; peak amplitude: p=0.45) but all
showed a dependence on concentration (p<0.01).
After averaging over time, peak flow at the different EPCs
was 1.2±0.2 ml/min at 0.045 mM, 1.4±0.2 ml/min at 0.45 mM
and 0.25±0.1 ml/min at 4.5 mM (not shown), only at the latter
concentration being significantly different from the control
condition (1.3±0.2) (p<0.01).
Basal masseter blood flow was 0.4±0.08 ml/min at the
control, increased to 0.5±0.11 ml/min at 0.045 mM (p=0.9) and
0.73±0.18 ml/min (p<0.01) at 0.45 mM and decreased to
0.22±0.18 ml/min at 4.5 mM (p<0.01).
The peak amplitude decreased from 0.85±0.33 ml/min
during the control to 0.64±0.25 ml/min at 0.45 mM (p<0.01) as
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)MaBF(ml/min) Fig. 2. (A) Original recording ofmasseteric artery blood flow (MaBF) inresponse to masseter musclecompressions (MC). Each compressioninduced a stereotyped hyperaemicresponse that followed the transientreduction in flow. The recording isextracted from the sequence of 10stimuli delivered before Gd3+administration, in one animal. (B) Effectof Gd3+ administration at increasingconcentration on the MC response. Eachcurve is the average of the responses to
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delivered during control (black) and 45
min after each Gd3+ infusion (grey
traces, see EPC in the legend), in the
same animal of Fig. 2A
shown in Fig. 3A. However, since basal flow was concomitantly
increased, the relative peak amplitude (=peak amplitude / basal
flow) was markedly attenuated by gadolinium at EPC=0.45 mM.
This effect is represented in Fig. 3B in which the average relative
peak amplitude is reported after normalization to control value,
taken as 100%. Relative peak amplitude was reduced from
195±77% of baseline, in control condition, to 100±42 % (at 0.45
mM, EPC), corresponding to an average reduction of 45±28%.
DISCUSSION
For the first time the vascular effect of Gd3+ were
investigated in vivo, by means of our recently-developed
experimental model (5).
The results showed that close arterial injection of Gd3+,
resulting in estimated plasma concentrations of 0.045 and 0.45
mM, progressively reduced the amplitude of the rapid
hyperaemic response to external muscle compression (to 65% of
control) while increasing basal blood flow (to 68% of control).
The marked effects observed at the highest concentration (4.5
mM) deserve a more careful consideration being possibly
produced by Gd3+ precipitation. Gadolinium administration did
not affect systemic variables such as ABP and HR, nor blood
flow in the contralateral masseteric artery.
Arterioles and small arteries usually develop and maintain
some degree of active force at their normal intravascular
pressure, allowing resistance to be modulated in two directions,
vasodilatation and vasoconstriction. In his famous model
Johnson (21) put forward the idea that arteriolar wall tension,
rather than the vessel diameter, is the regulated variable so that
vessel diameter is decreased in response to increased transmural
pressure, according to the Laplace's law. This model also
explains the "spontaneous" myogenic tone that develops in
resting conditions, in relation to intraluminal pressure (22). The
mechano-sensitive channels (MSC), largely expressed in both
endothelium and smooth muscle of blood vessels, are considered
to be involved in the vascular mechano-sensitivity (2, 9) that
mediates the myogenic response (9) as well as in the
maintenance of basal tone (12, 23-25).
Although a unique blocker of these mechano-sensitive
channels has not been identified, gadolinium chloride is
considered an effective mechano-sensitive channel blocker (26,
27) and its action on these channels has been documented by a
large numbers of in vitro studies performed on different tissues,
including vascular smooth muscle (26) and endothelium (28, 29).
In the present study, close arterial injection of Gd3+ resulted
in increased resting blood flow (69±71% at 0.45 mM), in the
absence of changes in arterial blood pressure. This reveals a
dilatation of resistance vessels and, to our knowledge, is the first
observation in vivo of the involvement of MSC channels in
resting myogenic tone. This result is in agreement with the
hyperpolarizing effect observed in isolated cerebral arteries upon
exposure to Gd3+ (30 ±M), which was attributed to a depressant
action exerted by the drug on non selective cation channels (30).
However, a dilatory effect has not been consistently observed in
in vitro studies (11, 23, 25), possibly due to the fact that single
different vascular segments were investigated. Such a limitation
does not apply to our in vivo model in which the whole muscolo-
vascular tree of the masseter muscle has been exposed to the
drug. Interestingly a dilatory effect of Gd3+ is compatible with
the general hypotensive effect observed upon systemic
administration by i.v. injection in cats (16), although in that
study specific vascular effects were not investigated.
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Fig. 3. Average effects of Gd3+ on basal
flow and peak amplitude of the MC
response. (A) average basal flow (dark
grey) and peak amplitude (light grey)
are reported before (CTRL) and at the
different time intervals after close
arterial injection of Gd3+ leading to
estimated plasma concentration of
0.045, and 0.45 mM. As illustrated by
the representative MC response
reported on the left, the total height of
each bar corresponds to average peak
flow. (B) Relative peak amplitude, i.e.,
referred to current basal flow is reported
in this bar diagram to highlight the
reduction induced by Gd3+. All values
have been normalized to control value
(CTRL). The presentation of the bar
diagram reflects the experimental
protocol, with arrows at the bottom
indicating Gd3+ administration and
labels indicating the corresponding
estimated plasma concentrations
(0.045, 0.45 mM). Data corresponding
to EPC of 4.5 mM were not reported
(see Discussion). † and * indicate
significant difference with respect to the
control condition (p<0.01) for basal
flow and peak amplitude, respectively.
Error bars indicate standard error (n=8).
The muscle vascular bed is known to have a large dilatory
capacity and MaBF was frequently observed to increase above
10 times the basal value in this same preparation, during
functional hyperaemia (14). On this basis, the decrease in the
hyperaemic response to MC cannot be attributed to a saturation
of the dilatory capacity associated to the increase in basal blood
flow. Moreover, in some instances the reduction in the MC
response was accompanied by negligible effects on basal blood
flow, thus resulting in a net reduction of peak flow (e.g., Fig. 2,
EPC=0.045 mM). These considerations indicate that the effect
on MC response is distinct from the effect on basal flow.
It is known that an increase in transmural pressure activates
the mechano-sensitive non-selective cation channels leading to
depolarization of vascular smooth muscle cells and increase of
intracellular [Ca++] which underlies the vasoconstriction
according to the classical myogenic response (27). Opposite
effects are considered to mediate the vasodilatation that follows
a reduction in transmural pressure, although this phenomenon
has been comparatively less investigated (9). Exposure to Gd3+
was shown to completely abolish the myogenic response in
isolated afferent arterioles of the rabbit kidney at a concentration
of 10 µM (13), while the same concentration was ineffective in
the rabbit basilar artery (31), suggesting a large variability
among different vascular compartments. In this respect, the
musculo-vascular compartment is known to exhibit a prominent
and rapid dilatation in response to mechanical stimulation,
particularly to stimuli that decrease transmural pressure, e.g.,
compression of the muscle (1, 3, 4, 32, 33) and occlusion of the
supplying artery (1). In addition, this rapid dilatory response has
been observed also in isolated muscle feed arteries (2) and
arterioles (25) subjected to external compression and to a drop in
internal pressure, respectively. In the latter study the authors
showed that the peak amplitude of the rapid dilatation following
transient reduction of intraluminal pressure (80–10–80 mmHg)
was significantly reduced by Gd3+ (10 µM), supporting the idea
that MSCs mediate at least part of the response (25). The effect
was however observed only for stimulus duration of 60 and 120
s and not for duration of 30 s. The MC stimulus adopted in the
present study likely produces a similar decrease in transmural
pressure of intramuscular blood vessels but, at difference with
the above mentioned study it lasts only 1 s. Moreover the
presently observed effects concern the response of the whole
musculo-vascular network, not just the response of the arteriolar
segment. Thus, although collected at higher theoretical Gd3+
concentration (EPC=450 µM, discussed below), the present
results extend the observation of Koller & Bagi (25) to the
response to 1-s lasting stimuli, in vivo, supporting the
involvement of Gd3+-sensitive MSCs in the mechanically-
induced rapid hyperaemia.
Blockade of mechano-sensitive structures is likely
responsible for the decreased vascular reactivity to mechanical
stimuli. It is presently not known whether these structures belong
to smooth muscle cells as in the classical myogenic response, to
the endothelium or both (34). The endothelium is known to
release vasodilatory substances, such as NO, prostaglandins and
K+, upon mechanical stimulation, not limited to shear stress (25,
35, 36). It is particularly interesting to consider the role of K+ that
has been recently shown to have a role in the contraction-induced
rapid dilatation (37, 38). In addition to being produced by skeletal
muscle fibers during contraction, K+ may also be released by the
endothelium upon activation of endothelial mechano-sensitive
TRP channels and then produce hyperpolarization and relaxation
of smooth muscle cells through activation of Kir channels and the
3Na+/2K+ pump (39, 40). That this pathway may underlie the MC
hyperaemic response is also suggested by the recent observation
that the dilatatory responses to K+ (36) and repetitive MC (15)
share a transient nature.
On the other hand, about 55% of the response was not
affected by Gd3+ at EPC=0.45 mM which suggests that other
mechano-trasduction pathways, possibly involving non Gd3+-
sensitive MSCs, extracellular matrix - integrins interactions and
intracellular adhesion molecules, may concur to the rapid
dilatory process (41).
In summary, different pathways may be hypothesized to
account for the dual effect of Gd3+ of increasing basal blood
flow and decreasing the hyperaemic response to MC. 1) The
tonic vasodilator effect may be mediated by the blockade of
NSCs in smooth muscle cells. The ensuing hyperpolarization
and reduced calcium entry would result in a relaxation of
smooth musculature and vessel dilatation (30). 2) The
desensitization to mechanical stimulation could result from
the blockade of endothelial mechano-sensitive channels
resulting in reduced release of vasodilatory factors,
presumably K+, and reduced vascular dilatations. In addition,
other actions of Gd3+ on non mechano-sensitive structures
might have contributed to these effects (see below). Further
experiments are necessary to test these hypotheses.
A major problem in the administration of Gd3+ (20-50
mg/kg) in vivo is related to its toxic effects, namely hypotension,
cardiac arrhythmias, A-V bundle blockade and ventricular
fibrillation, while no effects are reported below 0.5–1 mg/kg
(16). However, with close arterial Gd3+ administration the total
amount of drug injected was in the range 0.0017–0.17 mg/kg,
i.e., well below the toxic threshold.
In addition Gd3+, is also prone to precipitate and was
observed to lead to the formation of mineral emboli when
administered at high concentration (0.14–0.35 mmol/Kg,
corresponding to 3.1–7.8 mM plasma concentration) (42, 43).
This possibility could not be avoided in the present study and
was likely responsible for the sudden reduction of both basal
blood flow and of responsiveness to mechanical stimuli
observed at EPC of 4.5 mM.
Phenomena like Gd3+ precipitation (42, 43), binding to
anions, phosphate, carbonate and EGTA (44), as well as
diffusive processes in the interstitium all contribute to reduce the
actual Gd3+ concentration as compared to the EPC. This may
explain the reason why effects were presently observed at EPC
considerably larger than (33) concentrations effective in in vitro
studies.
Although Gd3+ is considered an effective MSC blocker,
largely used in functional experiments on in vitro vessel
preparation to study the role of stretch-activation cation channels
(10, 11, 26, 27), it is not very specific, blocking effects of
voltage-gated Ca++, Na+ and K+ channels having also being
reported (16). It cannot be excluded that this side-effects have
contributed to the observed increase of basal flow and decrease
of rapid hyperaemia. In particular a blockade of calcium
channels in smooth muscle cells could have contributed to the
observed tonic vasodilatation while a blockade of K+ channels
could have impaired a K+-based vasodilatory signalling from the
endothelium, thus contributing to attenuate the dilatory response
to MC.
The results suggest that Gd3+-sensitive MSCs take part in the
maintenance of basal vascular tone and to the mechanically-
induced rapid dilatation of muscle blood vessels. The fact that the
hyperaemic response is only partly attenuated by Gd3+ suggests
that other mechano-sensitive structures may also be involved.
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